Form 4: Kenvue Executive Granted 127,051 Restricted Stock Units

Kenvue's Group President North America, Carlos De Jesus, was granted 127,051 Restricted Stock Units, vesting over three years.

Summary

• Carlos De Jesus, Group President North America of Kenvue Inc. (KVUE), was granted 127,051 Restricted Stock Units (RSUs).
• The transaction date for this grant was March 2, 2026.
• These RSUs correspond one-for-one with the Company's common stock.
• The award vests in three equal installments on March 2, 2027, March 2, 2028, and March 2, 2029.
• Vesting is contingent upon Mr. De Jesus's continued service to the company through each vesting date.
• Following this transaction, Mr. De Jesus beneficially owns 127,051 Restricted Stock Units.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as it represents a routine executive compensation grant that aligns the interests of a key management figure with long-term shareholder value, without introducing new material financial information.

Positives

• The grant of 127,051 Restricted Stock Units to a key executive aligns management's long-term interests with those of shareholders.
• Equity compensation incentivizes the executive to contribute to the company's sustained growth and stock performance.

Negatives

• The RSUs do not provide immediate liquidity or cash value to the executive until they vest.
• The value of the compensation is tied to the future stock price of Kenvue, introducing market risk for the executive.

Risks

• The executive risks forfeiture of the unvested Restricted Stock Units if their service to Kenvue Inc. terminates before the scheduled vesting dates.
• The ultimate value of the compensation is subject to fluctuations in Kenvue's common stock price.

Future Outlook

The vesting schedule for the Restricted Stock Units indicates a commitment to retaining key executive talent and incentivizing long-term performance through March 2029, subject to continued service.

Industry Context

StockSavvy.ai notes that the grant of Restricted Stock Units is a standard practice in executive compensation across the consumer health industry and broader corporate landscape. This method aligns executive incentives with long-term shareholder value creation by tying a significant portion of compensation to the company's stock performance and continued service.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a form of executive compensation is a widely adopted practice, comparable to compensation structures at peer companies in the consumer health sector such as Procter & Gamble (PG), Johnson & Johnson (JNJ), and Colgate-Palmolive (CL).
• The multi-year vesting schedule (three equal installments over three years) is a common design for RSU awards, aiming to promote executive retention and long-term strategic focus, consistent with global benchmarks for executive equity incentives.

Stakeholder Impact

• Shareholders: The grant aligns the executive's financial interests with shareholder value creation, potentially leading to more focused long-term strategic decisions.
• Employees: May signal stability in executive leadership and a commitment to retaining key talent.

Next Steps

• Continued service of Carlos De Jesus through March 2, 2027, for the first RSU vesting.
• Continued service of Carlos De Jesus through March 2, 2028, for the second RSU vesting.
• Continued service of Carlos De Jesus through March 2, 2029, for the third RSU vesting.

Key Dates

Recommendation

This Form 4 reports a routine equity compensation grant to a key executive, which is a standard practice to align management incentives with shareholder interests. It does not contain new financial performance data or strategic shifts that would warrant a change in an existing investment recommendation for Kenvue Inc.

Keywords

Kenvue, KVUE, Form 4, Restricted Stock Units, RSU, executive compensation, insider transaction, Carlos De Jesus